Nanjing reagent zinc sulfate pharmaceutical excipient has been published by CDE for benchmarking against multiple national pharmacopoeia standards!

Nanjing Chemical Reagent Co., Ltd（Abbreviated as "Nanjing Reagent"）Produced byZinc sulfate pharmaceutical excipientFormally announced through the registration platform of the National Center for Drug Evaluation (CDE),CDE registration number F20250000654/F20250000653This marks that the product meets the standards of multiple countries such as ChP&USP&EP&JP, and has entered the ranks of international high-quality excipients.


Zinc sulfate pharmaceutical excipientIt is widely used in various drugs such as oral rehydration salts, zinc supplements, ophthalmic preparations, etc. The stability and reliability of its quality are directly related to the quality, efficacy, and safety of the drug. Nanjing Reagent offers customized services and can provide different packaging specifications (such as 500g/bottle, 25kg/bag) according to customer needs, and supports the addition of special packaging specifications to meet diversified application scenarios.


Nanjing reagentofZinc sulfate pharmaceutical excipientAll aspects of production technology, quality standards, safety, and effectiveness comply with national regulatory requirements. This provides clear guidance for pharmaceutical companies to choose compliant and high-quality excipients, and also marks that Nanjing Reagent has established a solid barrier in the research and development, production, and quality control system of pharmaceutical excipients, safeguarding the quality and safety of downstream formulation products.